EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
6.3.2.11 | Adenomatous Polyposis Coli |
25175604 |
Activation of Wnt/?-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. |
ongoing research unassigned |
3 0 |
6.3.2.11 | Carcinoma |
19741607 |
A luminal epithelial stem cell that is a cell of origin for prostate cancer. |
causal interaction therapeutic application unassigned |
3 4 0 |
6.3.2.11 | carnosine synthase deficiency |
33040025 |
Carnosine synthase deficiency is compatible with normal skeletal muscle and olfactory function but causes reduced olfactory sensitivity in aging mice. |
causal interaction therapeutic application unassigned |
3 1 0 |
6.3.2.11 | Hyperglycemia |
14610252 |
Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves. |
unassigned |
0 |
6.3.2.11 | Myocardial Ischemia |
32515247 |
Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury. |
causal interaction unassigned |
1 0 |
6.3.2.11 | Neoplasms |
19741607 |
A luminal epithelial stem cell that is a cell of origin for prostate cancer. |
causal interaction therapeutic application unassigned |
3 4 0 |
6.3.2.11 | Neoplasms |
25241035 |
Single luminal epithelial progenitors can generate prostate organoids in culture. |
causal interaction ongoing research therapeutic application unassigned |
1 1 2 0 |
6.3.2.11 | Neoplasms |
28833669 |
A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers. |
causal interaction ongoing research therapeutic application unassigned |
1 1 2 0 |
6.3.2.11 | Neuroblastoma |
30504220 |
2-Oxo-histidine-containing dipeptides are functional oxidation products. |
unassigned |
0 |
6.3.2.11 | Prostatic Neoplasms |
19741607 |
A luminal epithelial stem cell that is a cell of origin for prostate cancer. |
causal interaction therapeutic application unassigned |
3 4 0 |